ALXO
Alx Oncology Holdings
1.20$
-0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.0% | +3.4% | +2.8% | +1.8% | -4.5% | -1.4% | -9.5% | -19.9% | -1.3% | -0.7% | -42.7% | – | |
| – | -3.5% | +4.6% | +3.1% | -4.1% | -15.7% | -11.0% | -59.0% | +18.0% | +7.3% | -7.3% | +6.9% | – | |
| – | -97.7% | -2,685.5% | – | -121.3% | – | – | -591.8% | – | -65.2% | -592.2% | – | – | |
| – | -88.6% | +0.0% | -39.2% | +65.6% | -59.7% | +0.0% | -21.7% | +19.1% | -12.5% | +2.0% | -66.0% | – | |
| – | -230.1% | – | -96.6% | +2,732.7% | +29.2% | -16.7% | -19.3% | -4.1% | -47.5% | -1,035.1% | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | -140.0% | – | – | – | |
| – | – | – | – | – | -78.8% | +303.9% | -22.8% | -32.5% | +312.5% | +144.2% | – | – | |
| – | – | -94.8% | +779.8% | -99.1% | +30.7% | -80.2% | -441.5% | -28.4% | – | +20,489.2% | -99.9% | – | |
| – | – | -396.4% | – | -62.0% | +157.9% | +108.0% | -143.1% | – | -270.7% | – | -159.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.